Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.06 | 0.7 |
mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.067 | 0.7 |
mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |